CAR-T cells amplified ex vivo with IL-15 were characterized by a less differentiated phenotype, decreased expression of exhaustion and pro-apoptotic molecules, improved mitochondrial metabolism, and infusion demonstrated a greater anti-tumor response in vivo (Singh et al., 2016; Alizadeh et al., 2019). Here, IL15 is linked to neoplasm.